Cytokinetics | CYTK - Interest Expense On Debt


Cytokinetics reported $26.32M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Acadia Pharmaceuticals USD 0 4.12M Sep/2024
Amgen USD 653M 32M Dec/2025
Bayer EUR 762M 267M Sep/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 480M 5M Sep/2025
Cytokinetics USD 26.32M 2.06M Sep/2025
Eisai JPY 1.44B 526M Sep/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Exelixis USD 23.4M 3.9M Sep/2023
Geron USD 8.64M 128K Sep/2025
Halozyme Therapeutics USD 4.3M 98K Sep/2025
Ionis Pharmaceuticals USD 18M 1000K Sep/2025
Ligand Pharmaceuticals USD 910K 243K Sep/2025
Merck USD 412M 85M Dec/2025
Novartis USD 281M 8M Sep/2025
Pfizer USD 711M 59M Dec/2025
Regeneron Pharmaceuticals USD 12.2M 7.1M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR -25M 252M Dec/2025